Abstract
The Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) is funded by the National Cancer Institute and is based at the University of North Carolina. The C-CCNE features interactions between physical and biological scientists in a series of projects and cores that work together to quickly harness innovations in nanotechnology for the early diagnosis and treatment of cancer. Two key focus areas of the C-CCNE are, first, the selective delivery of drugs and imaging agents utilizing advanced nanoparticle technology, and second, novel approaches to imaging and radiotherapy utilizing carbon nanotube-based x-ray sources.
Bibliography
- 1 Ferrari M, Barker A, Downing G: A cancer nanotechnology strategy. NanoBiotechnology1,129–131 (2005).
- 2 Gratton SEA, Ropp PA, Pohlhaus PD et al.: The effect of particle design on cellular internalization pathways. Proc. Natl Acad. Sci. USA105,11613–11618 (2008).
- 3 Gratton SEA, Williams SS, Napier ME et al.: The pursuit of a scalable nanofabrication platform for use in material and life science applications. Acc. Chem. Res.41,1685–1695 (2008).
- 4 Zhang J, Yang G, Cheng Y et al.: A stationary scanning x-ray source based on carbon nanotube field emitters. Appl. Phys. Lett.86,184104 (2005)
- 5 Cao G, Lee YZ, Peng R et al.: A dynamic micro-CT scanner based on a carbon nanotube field emission x-ray source. Phys. Med. Biol.54,2323–2340 (2009)
- 6 Ptak K, Farrell D, Panaro NJ, Grodzinski P, Barker AD: The NCI alliance for nanotechnology in cancer: achievement and path forward. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.2(5),450–460 (2010).
- 101 National Cancer Institute’s Alliance for Nanotechnology in Cancer http://nano.cancer.gov
- 102 National Nantotechnology Initiative www.nano.gov
- 103 Carolina Center of Cancer Nanotechnology Excellence http://carolinaccne.org